$ARQQ

Wilder Ben Simon sold $5K of ARQQ

Wilder Ben Simon (Chief Operating Officer) sold 221 shares of Arqit Quantum Inc. (ARQQ) at $24.47 across 2 trades on 2026-10-02.

Original reporting
SEC EDGAR · Wilder Ben Simon
Published Oct 6, 2026, 11:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 11:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ARQQ
Bearish
high confidence
Mentioned
$ARQQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARQQBearishLow
01

Why it matters

The disclosed sale is small and unlikely to move the stock materially, but it adds transparency to insider activity.

02

Market read

A routine insider sale with limited price impact; primarily of interest to compliance and monitoring teams.

03

What to watch

Insider still holds 4,251 shares, representing a modest stake; no change in control.

Relevance 3/10Novelty 3/10Timing: after-hours

Background

SEC Form 4 filing provides the first public disclosure of the insider transaction.

Company-level read

Ticker impact

$ARQQBearishHigh confidence
Context

Form 4 disclosed COO Wilder Ben Simon sold 221 shares for $5.4K, a routine insider sale.

Expected impact

likely slight downward pressure as market prices in the insider sale

Evidence & confidence

The sale is small relative to holdings and market cap, but any insider sell can trigger short-term bias.

Market effects

No broader sector impact; the sale is company‑specific.

None

None

Counterpoint

The sale may be a routine liquidity move and not indicative of future weakness.

Key entities

  • Wilder Ben Simon

    Chief Operating Officer of Arqit Quantum Inc.

  • Arqit Quantum Inc.

    Quantum communications firm listed on NASDAQ under ARQQ.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QNTMedAI 9/10

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).